Literature DB >> 32278107

Surgical site infections after pancreaticoduodenectomy: Preoperative biliary system interventions and antimicrobial prophylaxis.

Çağrı Bilgiç1, Şiran Keske2, Erman Sobutay1, Uğur Can1, Serkan Zenger1, Bülent Gürbüz1, Önder Ergönül3, Orhan Bilge4.   

Abstract

BACKGROUND: The rate of surgical site infection (SSI) after pancreaticoduodenectomy (PD) is high and insertion of preoperative bile duct catheterization (PBDC) predispose a high risk of SSI with multidrug resistant (MDR) microorganisms. AIM: To describe the effects of PBDC and the prophylaxis in development of SSI.
METHODS: We conducted a retrospective study between January 01, 2010 and December 2018 including the patients with PD and total pancreatectomy.
FINDINGS: In total 214 consecutive patients were included. The PBDC was inserted to 63 (29%) patients. The rate of intraoperative bile fluid culture positivity was higher among the patients with PBDC (84% vs. 17% respectively, p<0.001). The SSI was detected in 52 patients (24%). In multivariate analysis, the rate of SSI was found to be higher among the patients with PBDC (OR: 2.33, 95% Cl: 1.14-4.76, p=0.02). As the etiologic agents of SSI, Pseudomonas spp. and MDR pathogens were mainly detected in PBDC group. The resistance to ampicillin-sulbactam was significantly higher in the PBDC group (87.5% vs. 25%, p=0.012). The similar bacterial species both in bile fluid and the surgical site were detected in 11 (21%) patients with SSI. Among 8 patients (15%), antimicrobial susceptibility was the same. Only in five out of 52 (10%) patients, the SSI pathogens was susceptible to the agent that was used for surgical prophylaxis.
CONCLUSION: Unnecessary catheterizations should be avoided. By considering the increasing prevalence of resistant bacteria as the cause of SSI, the clinicians should closely follow-up their patients for choosing the proper antimicrobials.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Pancreaticoduodenectomy; Preoperative biliary system interventions; Surgical prophylaxis; Surgical site infections

Year:  2020        PMID: 32278107     DOI: 10.1016/j.ijid.2020.04.005

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  4 in total

1.  Effect of bacterial contamination in bile on pancreatic cancer cell survival.

Authors:  Hannah R Shrader; Ann M Miller; Ann Tomanek-Chalkley; Ashley McCarthy; Kristen L Coleman; Po Hien Ear; Ashutosh K Mangalam; Aliasger K Salem; Carlos H F Chan
Journal:  Surgery       Date:  2020-10-22       Impact factor: 3.982

2.  Optimizing Nanopore Sequencing for Rapid Detection of Microbial Species and Antimicrobial Resistance in Patients at Risk of Surgical Site Infections.

Authors:  Emma Whittle; Jennifer A Yonkus; Patricio Jeraldo; Roberto Alva-Ruiz; Heidi Nelson; Michael L Kendrick; Thomas E Grys; Robin Patel; Mark J Truty; Nicholas Chia
Journal:  mSphere       Date:  2022-02-16       Impact factor: 4.389

Review 3.  Antibiotic Prophylaxis for Hepato-Biliopancreatic Surgery-A Systematic Review.

Authors:  Francesca Steccanella; Paolo Amoretti; Maria Rachele Barbieri; Fabio Bellomo; Alessandro Puzziello
Journal:  Antibiotics (Basel)       Date:  2022-02-01

4.  A high bile acid environment promotes apoptosis and inhibits migration in pancreatic cancer.

Authors:  Shaopu Zhu; Kang Yang; Shiyi Yang; Li Zhang; Maoming Xiong; Jiawei Zhang; Bo Chen
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.